Get notified when RIGL files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: RIGL RIGEL PHARMACEUTICALS INC 8-K

Rigel shareholders approve equity plan expansion amid elevated dilution concerns

Filed May 20, 2026 · Period ending May 14, 2026 · ~1 min read

Key Changes

  • medium

    Shareholders approved 500,000-share increase to 2018 Equity Incentive Plan with 63.0% support (6,497,964 for vs 3,813,701 against); 37.0% opposition reflects elevated concern about equity dilution.

    Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →
  • low

    Shareholders approved 360,000-share increase to Employee Stock Purchase Plan, expanding pool for employee stock purchases.

    Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
  • low

    Three directors elected to serve until 2029: Alison Hannah (85.5% support), Walter Moos (97.7%), and Raul Rodriguez (98.2%).

    Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →

1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (STZ 10-Q) is open in full — no account needed.

Partner

Trade RIGL commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jul 8, 2026 · How we verify